Monday, November 23, 2009

Many movers & analyst calls; Sprint CEO interview; S&P nails Citi; Colgate merger bait: value in biotech; eBay outage

As always, here are the top major media headline summaries from Reuters, WSJ, NYTimes, FT, and Bloomberg. Mondays' top 10 Anlayst Upgrades, Downgrades, Initiations are in AXP, COF, DE, DHI, JEF, NITE, NDAQ, SLB, SBUX, WLP. This morning'stop day trader alerts are in SEED, YONG, FEED, CEPH, TECD, DDRX, GMCR. Cephalon was one of the 5 'value screens' in biotechs and drug stocks we ran at BioHealthInvestor.com over the weekend. We also ran the "unusual options trading" as we saw late Friday. Today's top stock and market rumors are out and will be updated throughout the trading day.

We ran an
exclusive this morning that is a CEO interview with Dan Hesse of Sprintg Nextel (NYSE: S). S&P is out with a new change and new caution to its review of the world's largest banks. This has Citi and UBS under the black light, yet it is not an imminent S&P downgrade.

The New York Times is showing how the annual interest payments from the US government will
jump to $700 billion a year in 2019, about $500 million more than today.

Is Colgate Palmolive (NYSE: CL) the
next consumer products buyout?

eBay (EBAY) may have costs auctioneers millions and millions after an
outage killed the search functions on Saturday.

This week's
top 10 earnings on deck with previews for each are in HPQ, TSN, CPB, LDK, TECD, BKS, BGP, JCG, DLTR, DE.

No comments: